title: Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
abstract: BACKGROUND
  Besides other molecular functions, the lysyl oxidase gene (LOX) has been assumed and shown to have a tumor suppressive function in vitro and in vivo. The cancer-related functions of both LOX and LOXL2 have not yet been investigated in squamous cell carcinoma of the head and neck (HNSCC).
  
  
  METHODS
  We examined the mRNA levels of LOX and LOXL2 in ten malignantly transformed cell lines and sixteen malignant tissue samples of different graded and staged HNSCC by RT-PCR.
  
  
  RESULTS
  The LOX-mRNA level in both cell lines and tissues of HNSCC was markedly reduced as opposed to benign keratinocyte cell lines and mucosal tissue samples of the upper aerodigestive tract. Similar results were shown for LOXL2-mRNA levels in cell lines, whereas no reduction of LOXL2-mRNA levels was found in the malignantly transformed tissues.
  
  
  CONCLUSIONS
  These findings support the presumption that LOX is involved in tumor suppressive processes and also of LOXL2 playing a role in malignant transformation.
authors.affiliation: Department of Otolaryngology, University of Marburg, Deutschhausstr. 3, 35037 Marburg, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Rost
authors.forename: V
authors.initials: V
authors.lastname: Pyritz
authors.forename: I O
authors.initials: IO
authors.lastname: Rathcke
authors.forename: T
authors.initials: T
authors.lastname: Görögh
authors.forename: A A
authors.initials: AA
authors.lastname: Dünne
authors.forename: J A
authors.initials: JA
authors.lastname: Werner
mesh_terms: D000594:Amino Acid Oxidoreductases / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D002294:Carcinoma, Squamous Cell / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D002471:Cell Transformation, Neoplastic; D020869:Gene Expression Profiling; D016147:Genes, Tumor Suppressor; D006258:Head and Neck Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D006801:Humans; D015603:Keratinocytes / Q000201:enzymology; D009092:Mucous Membrane / Q000201:enzymology; D005810:Multigene Family; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D008249:Protein-Lysine 6-Oxidase / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D012334:RNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D012137:Respiratory System / Q000166:cytology / Q000201:enzymology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured / Q000201:enzymology
chemical_list: D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D000594:Amino Acid Oxidoreductases; C119091:LOXL2 protein, human; D008249:Protein-Lysine 6-Oxidase